October 25, 2021
RFA-RM-22-001 - Limited Competition: Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Optional)
NOT-OD-20-031- Notice of NIH’s Interest in Diversity
NOT-EY-22-001- Notice to Rescind NOT-EY-21-001, "Notice of Special Interest (NOSI): National Research Service Award (NRSA) F32 Postdoctoral Fellowship Applications from Individuals from Diverse Backgrounds, Including Under-Represented Minorities"
RFA-MH-22-175 - Emergency Award HEAL Initiative: Optimizing Existing Evidence-Based Multi-Component Service Delivery Interventions for People with Opioid Use Disorder, Co-Occurring Conditions, and/or Suicide Risk (R01 Clinical Trials Optional)
NOT-HG-22-014 - Solicitation of Nominations for the 2022 National Human Genome Research Institute’s Outstanding Award for Enhancing Diversity, Equity, Inclusion, and Accessibility in the Genomics Workforce
NATIONAL INSTITUTES OF HEALTH (NIH)
NIH’s mission is to seek fundamental knowledge about the nature and behavior of living systems and to apply that knowledge to enhance health, lengthen life, and reduce illness and disability. To achieve this mission, NIH substantially invests in research to improve public health; it also devotes substantial resources to cultivate a robust and diverse biomedical research workforce.
On November 22, 2019, NIH issued its latest Notice of Interest in Diversity, explaining NIH’s compelling interest in supporting a diverse biomedical research workforce that includes individuals from groups that are currently underrepresented in the biomedical, clinical, behavioral and social sciences, such as individuals from racial and ethnic groups that have been shown by the National Science Foundation to be underrepresented in health-related sciences on a national basis, individuals with disabilities, individuals from disadvantaged backgrounds, and women at the faculty level.
Diversity within the NIH-supported scientific workforce fosters innovation, enhances global competitiveness, improves the quality of research and research outcomes. In this notice, we reaffirm our commitment to supporting a sustainable and diverse biomedical research workforce. As we state in our parent announcements (for example, PA-20-185– NIH Research Project Grant [Parent R01 Clinical Trial Not Allowed]), individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are strongly encouraged to work with their organizations to apply for NIH support.